Richard Joel Paolone

Executive

CA·SEDI

Canam Biotech Inc.(formerly HemaGenetics Technologies Corp.)

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 08 Sept 2020 for Canam Biotech Inc.(formerly HemaGenetics Technologies Corp.), €64.

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Richard Joel Paolone: trading record in brief

All filings by Richard Joel Paolone on record concern Canam Biotech Inc.(formerly HemaGenetics Technologies Corp.). The record holds 2 filings, for trades running from 5 July 2019 to 3 September 2020.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The newest entry dates from 8 September 2020: a share grant of €64, in Canam Biotech Inc.(formerly HemaGenetics Technologies Corp.). This summary is built from SEDI disclosures alone and does not predict where the share price will go.